{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T05:12:45Z","timestamp":1774501965032,"version":"3.50.1"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:p>Carcinoma ex pleomorphic adenoma (CXPA) is an aggressive epithelial and\/or myoepithelial neoplasm that arises in association with a pleomorphic adenoma (PA). Its etiopathogenesis remains poorly understood, but it is believed that the development of this tumor is due to the accumulation of genetic, protein, metabolic, and epigenetic alterations in a PA. A retrospective review of the Salivary Gland Tumor Registry in Pilsen yielded 84 CXPA, namely 25\/84 salivary duct carcinoma (SDC), 15\/84 myoepithelial carcinoma (MC), 1\/84 epithelial-myoepithelial carcinoma (EMC), and 1\/84 adenoid cystic carcinoma (AdCC). All 84 CXPA cases were analyzed by next-generation sequencing (NGS) and\/or fluorescence in situ hybridization (FISH). Forty-three tumors originally diagnosed as CXPA (43\/84, 51.2%) showed some molecular alteration. Fusion transcripts were identified in 12\/16 (75%) CXPA, including <jats:italic toggle=\"yes\">LIFR::PLAG1, CTNNB1::PLAG1, FGFR1::PLAG1<\/jats:italic>, and a novel fusion, <jats:italic toggle=\"yes\">HMGA2::LINC02389<\/jats:italic>. Most of the fusions were confirmed by FISH using <jats:italic toggle=\"yes\">PLAG1<\/jats:italic> (6\/11) and <jats:italic toggle=\"yes\">HMGA2<\/jats:italic> (1\/1) gene break probes. Split signals indicating gene break were identified by FISH for <jats:italic toggle=\"yes\">PLAG1<\/jats:italic> (12\/17), <jats:italic toggle=\"yes\">HMGA2<\/jats:italic> (3\/4), <jats:italic toggle=\"yes\">EWSR1<\/jats:italic> (7\/22), and <jats:italic toggle=\"yes\">MYB<\/jats:italic> (2\/7). Concerning pathogenic mutations, only CXPA with epithelial differentiation (SDC) presented these alterations, including <jats:italic toggle=\"yes\">HRAS<\/jats:italic> mutation (2\/4), <jats:italic toggle=\"yes\">TP53<\/jats:italic> (1\/4), <jats:italic toggle=\"yes\">PTEN<\/jats:italic> (1\/4), and <jats:italic toggle=\"yes\">ATK1<\/jats:italic> (1\/4). In addition, amplifications in <jats:italic toggle=\"yes\">ERBB2<\/jats:italic> (17\/35), <jats:italic toggle=\"yes\">MDM2<\/jats:italic> (1\/4), and <jats:italic toggle=\"yes\">EWSR1<\/jats:italic> (1\/7) were detected. A novel finding was the discovery of an <jats:italic toggle=\"yes\">HMGA2::LINC02389<\/jats:italic> fusion in 1 patient with EMC ex-PA. The present results indicate that molecular profiling of CXPA with myoepithelial differentiation (MC) tends to reveal chromosomal fusion events, whereas CXPA with epithelial differentiation (SDC) tends to have a higher frequency of pathogenic mutations and gene amplifications.<\/jats:p>","DOI":"10.1097\/pas.0000000000002307","type":"journal-article","created":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T14:02:36Z","timestamp":1727359356000},"page":"1491-1502","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Expanding the Molecular Spectrum of Carcinoma Ex Pleomorphic Adenoma"],"prefix":"10.1097","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5045-6960","authenticated-orcid":false,"given":"Reydson Alcides","family":"de Lima-Souza","sequence":"first","affiliation":[{"name":"Department of Oral Diagnosis, Piracicaba Dental School, University of Campinas (UNICAMP), Piracicaba"},{"name":"Department of Pathology, School of Medical Sciences, University of Campinas (UNICAMP), Campinas, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9944-9734","authenticated-orcid":false,"given":"Albina","family":"Altemani","sequence":"additional","affiliation":[{"name":"Department of Pathology, School of Medical Sciences, University of Campinas (UNICAMP), Campinas, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Michal","sequence":"additional","affiliation":[{"name":"Bioptic Laboratory Ltd"},{"name":"Department of Pathology, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3694-5025","authenticated-orcid":false,"given":"Fernanda Viviane","family":"Mariano","sequence":"additional","affiliation":[{"name":"Department of Pathology, School of Medical Sciences, University of Campinas (UNICAMP), Campinas, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilmo","family":"Leivo","sequence":"additional","affiliation":[{"name":"Department of Pathology, Institute of Biomedicine, University of Turku, Turku, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alena","family":"Sk\u00e1lov\u00e1","sequence":"additional","affiliation":[{"name":"Bioptic Laboratory Ltd"},{"name":"Department of Pathology, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,9,26]]},"reference":[{"key":"R2-20250608","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ijom.2013.02.012","article-title":"Carcinoma ex pleomorphic adenoma in a Brazilian population: clinico-pathological analysis of 38 cases","volume":"42","author":"Mariano","year":"2013","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"suppl 1","key":"R3-20250608","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1007\/s12105-013-0454-z","article-title":"Carcinoma ex pleomorphic adenoma, with particular emphasis on early lesions","volume":"7","author":"Di Palma","year":"2013","journal-title":"Head Neck Pathol"},{"key":"R4-20250608","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1365-2559.2005.02157.x","article-title":"Carcinoma ex pleomorphic adenoma (CXPA): immunoprofile of the cells involved in carcinomatous progression","volume":"46","author":"Altemani","year":"2005","journal-title":"Histopathology"},{"key":"R5-20250608","doi-asserted-by":"crossref","first-page":"105262","DOI":"10.1016\/j.oraloncology.2021.105262","article-title":"Secretory carcinoma ex pleomorphic adenoma of the submandibular gland: an immunohistochemical study","volume":"120","author":"de Lima-Souza","year":"2021","journal-title":"Oral Oncol"},{"key":"R6-20250608","doi-asserted-by":"crossref","first-page":"102279","DOI":"10.1016\/j.amjoto.2019.102279","article-title":"Carcinoma ex pleomorphic adenoma: a review of incidence, demographics, risk factors, and survival","volume":"40","author":"Gupta","year":"2019","journal-title":"Am J Otolaryngol"},{"key":"R7-20250608","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/odi.14102","article-title":"Discovery proteomics reveals potential protein signature associated with malignant phenotype acquisition in pleomorphic adenoma","volume":"29","author":"de Lima\u2010Souza","year":"2023","journal-title":"Oral Dis"},{"key":"R8-20250608","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.oooo.2019.08.016","article-title":"Somatic copy number alterations in pleomorphic adenoma and recurrent pleomorphic adenoma","volume":"129","author":"Mariano","year":"2020","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"R9-20250608","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/s10792-021-02096-2","article-title":"Metabolic alterations in carcinoma ex pleomorphic adenoma development of lacrimal glands","volume":"42","author":"de Lima-Souza","year":"2022","journal-title":"Int Ophthalmol"},{"key":"R10-20250608","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/gcc.23020","article-title":"Fusion-positive salivary gland carcinomas","volume":"61","author":"Sk\u00e1lov\u00e1","year":"2022","journal-title":"Genes Chromosomes Cancer"},{"key":"R11-20250608","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/PAS.0b013e3181d9efcc","article-title":"Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity","volume":"34","author":"Sk\u00e1lov\u00e1","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R12-20250608","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/PAS.0000000000001783","article-title":"HMGA2-WIF1 rearrangements characterize a distinctive subset of salivary pleomorphic adenomas with prominent trabecular (canalicular adenoma-like) morphology","volume":"46","author":"Agaimy","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"R13-20250608","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1097\/PAS.0000000000001133","article-title":"Molecular profiling of salivary gland intraductal carcinoma revealed a subset of tumors harboring NCOA4-RET and novel TRIM27-RET fusions","volume":"42","author":"Sk\u00e1lov\u00e1","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R14-20250608","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.humpath.2020.07.009","article-title":"What is hiding behind S100 protein and SOX10 positive oncocytomas? Oncocytic pleomorphic adenoma and myoepithelioma with novel gene fusions in a subset of cases","volume":"103","author":"Ban\u011b\u010dkov\u00e1","year":"2020","journal-title":"Hum Pathol"},{"key":"R15-20250608","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/PAS.0000000000001591","article-title":"Molecular profiling of clear cell myoepithelial carcinoma of salivary glands with EWSR1 rearrangement identifies frequent PLAG1 gene fusions but no EWSR1 fusion transcripts","volume":"45","author":"Sk\u00e1lov\u00e1","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"R16-20250608","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/PAS.0000000000000364","article-title":"Clear cell myoepithelial carcinoma of salivary glands showing EWSR1 rearrangement","volume":"39","author":"Sk\u00e1lov\u00e1","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R17-20250608","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.humpath.2019.08.009","article-title":"Biomarker immunoprofile and molecular characteristics in salivary duct carcinoma: clinicopathological and prognostic implications","volume":"93","author":"Santana","year":"2019","journal-title":"Hum Pathol"},{"key":"R18-20250608","doi-asserted-by":"crossref","first-page":"59023","DOI":"10.18632\/oncotarget.19812","article-title":"Biomarker immunoprofile in salivary duct carcinomas: clinicopathological and prognostic implications with evaluation of the revised classification","volume":"8","author":"Takase","year":"2017","journal-title":"Oncotarget"},{"key":"R19-20250608","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.5858\/arpa.2018-0902-SA","article-title":"Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists clinical practice guideline focused update","volume":"142","author":"Wolff","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"R20-20250608","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00428-018-2349-6","article-title":"Prognostic significance of 1p36 locus deletion in adenoid cystic carcinoma of the salivary glands","volume":"473","author":"\u0160teiner","year":"2018","journal-title":"Virchows Arch"},{"key":"R21-20250608","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1097\/PAS.0000000000001129","article-title":"Dysplastic lipoma: a distinctive atypical lipomatous neoplasm with anisocytosis, focal nuclear atypia, p53 overexpression, and a lack of MDM2 gene amplification by FISH; a report of 66 cases demonstrating occasional multifocality and a rare association Wi","volume":"42","author":"Michal","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R22-20250608","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1002\/cncr.30179","article-title":"Subsets of salivary duct carcinoma defined by morphologic evidence of pleomorphic adenoma, PLAG1 or HMGA2 rearrangements, and common genetic alterations","volume":"122","author":"Chiosea","year":"2016","journal-title":"Cancer"},{"key":"R23-20250608","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1038\/s41379-020-0576-2","article-title":"Molecular patterns in salivary duct carcinoma identify prognostic subgroups","volume":"33","author":"Mueller","year":"2020","journal-title":"Mod Pathol"},{"key":"R24-20250608","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/sj.onc.1207013","article-title":"Microarray screening for target genes of the proto-oncogene PLAG1","volume":"23","author":"Voz","year":"2004","journal-title":"Oncogene"},{"key":"R25-20250608","first-page":"106","article-title":"PLAG1, the main translocation target in pleomorphic adenoma of the salivary glands, is a positive regulator of IGF-II","volume":"60","author":"Voz","year":"2000","journal-title":"Cancer Res"},{"key":"R26-20250608","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/nrc2271","article-title":"Roles of HMGA proteins in cancer","volume":"7","author":"Fusco","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"R27-20250608","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1101\/gad.1540407","article-title":"The tumor suppressor microRNA let-7 represses the HMGA2 oncogene","volume":"21","author":"Lee","year":"2007","journal-title":"Genes Dev"},{"key":"R28-20250608","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/gcc.22979","article-title":"Targeted RNA sequencing in the routine clinical detection of fusion genes in salivary gland tumors","volume":"60","author":"Bubola","year":"2021","journal-title":"Genes Chromosom Cancer"},{"key":"R29-20250608","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/his.14840","article-title":"Salivary carcinosarcoma: insight into multistep pathogenesis indicates uniform origin as sarcomatoid variant of carcinoma ex pleomorphic adenoma with frequent heterologous elements","volume":"82","author":"Ihrler","year":"2023","journal-title":"Histopathology"},{"key":"R30-20250608","doi-asserted-by":"crossref","first-page":"7483","DOI":"10.1038\/s41598-024-57836-y","article-title":"Long non-coding RNA LINC-PINT as a novel prognostic biomarker in human cancer: a meta-analysis and machine learning","volume":"14","author":"Lin","year":"2024","journal-title":"Sci Rep"},{"key":"R31-20250608","doi-asserted-by":"crossref","first-page":"156444","DOI":"10.1016\/j.cyto.2023.156444","article-title":"Long non-coding RNA LINC00491 accelerates head and neck squamous cell carcinoma progression through regulating miR-508-3p\/SATB1 axis and activating Wnt signaling pathway","volume":"175","author":"Cui","year":"2024","journal-title":"Cytokine"},{"key":"R32-20250608","doi-asserted-by":"crossref","first-page":"103592","DOI":"10.1016\/j.critrevonc.2022.103592","article-title":"Mutational and immunologic Landscape in malignant salivary gland tumors harbor the potential for novel therapeutic strategies","volume":"170","author":"Witte","year":"2022","journal-title":"Crit Rev Oncol Hematol"},{"key":"R33-20250608","doi-asserted-by":"crossref","first-page":"100150","DOI":"10.1016\/j.modpat.2023.100150","article-title":"Loss of CDKN2A\/B is a molecular marker of high-grade histology and is associated with aggressive behavior in acinic cell carcinoma","volume":"36","author":"Dogan","year":"2023","journal-title":"Mod Pathol"},{"key":"R34-20250608","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.oraloncology.2017.07.030","article-title":"Role of CDKN2A\/p16 expression in the prognostication of oral squamous cell carcinoma","volume":"73","author":"Padhi","year":"2017","journal-title":"Oral Oncol"},{"key":"R35-20250608","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/gcc.20719","article-title":"Unfavorable prognosis of CRTC1-MAML2 positive mucoepidermoid tumors with CDKN2A deletions","volume":"49","author":"Anzick","year":"2010","journal-title":"Genes Chromosom Cancer"},{"key":"R36-20250608","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.3390\/cancers13143445","article-title":"Akt isoforms: a family affair in breast cancer","volume":"13","author":"Basu","year":"2021","journal-title":"Cancers"},{"key":"R37-20250608","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1158\/1078-0432.CCR-16-0637","article-title":"Comprehensive molecular characterization of salivary duct carcinoma reveals actionable targets and similarity to apocrine breast cancer","volume":"22","author":"Dalin","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"suppl 1","key":"R38-20250608","first-page":"E1838","article-title":"Salivary duct carcinoma: clinicopathologic features, morphologic spectrum, and somatic mutations","volume":"38","author":"Luk","year":"2016","journal-title":"Head Neck"},{"key":"R39-20250608","doi-asserted-by":"crossref","first-page":"6061","DOI":"10.1158\/1078-0432.CCR-15-2568","article-title":"Profiling of 149 salivary duct carcinomas, carcinoma ex pleomorphic adenomas, and adenocarcinomas, not otherwise specified reveals actionable genomic alterations","volume":"22","author":"Wang","year":"2016","journal-title":"Clin Cancer Res"},{"key":"R40-20250608","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/s41379-021-00999-0","article-title":"ERBB2 amplification status in 67 salivary duct carcinomas assessed by immunohistochemistry, fluorescence in situ hybridization, and targeted exome sequencing","volume":"35","author":"Ferguson","year":"2022","journal-title":"Mod Pathol"},{"key":"R41-20250608","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1186\/s12885-016-2766-3","article-title":"Prognosis of breast cancer molecular subtypes in routine clinical care: a large prospective cohort study","volume":"16","author":"Hennigs","year":"2016","journal-title":"BMC Cancer"},{"key":"R42-20250608","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/j.humpath.2015.07.014","article-title":"Dual gain of HER2 and EGFR gene copy numbers impacts the prognosis of carcinoma ex pleomorphic adenoma","volume":"46","author":"Nishijima","year":"2015","journal-title":"Hum Pathol"},{"key":"R43-20250608","doi-asserted-by":"crossref","first-page":"105287","DOI":"10.1016\/j.oraloncology.2021.105287","article-title":"Eribulin in combination with HER2-targeted antibodies for successful treatment of metastatic salivary duct carcinoma: a report of two cases","volume":"120","author":"Fujimi","year":"2021","journal-title":"Oral Oncol"},{"key":"R44-20250608","doi-asserted-by":"crossref","first-page":"106541","DOI":"10.1016\/j.oraloncology.2023.106541","article-title":"Partial response to RC-48 as palliative treatment in a patient with locallocally advanced carcinoma ex pleomorphic adenoma harboring a HER2 mutation: a case report","volume":"146","author":"Yu","year":"2023","journal-title":"Oral Oncol"},{"key":"R45-20250608","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.path.2018.10.007","article-title":"Mesenchymal tumors with EWSR1 gene rearrangements","volume":"12","author":"Thway","year":"2019","journal-title":"Surg Pathol Clin"},{"key":"R46-20250608","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/his.12269","article-title":"The diversity of soft tissue tumours with EWSR1 gene rearrangements: a review","volume":"64","author":"Fisher","year":"2014","journal-title":"Histopathology"},{"key":"R47-20250608","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/gcc.20819","article-title":"EWSR1-POU5F1 fusion in soft tissue myoepithelial tumors. A molecular analysis of sixty-six cases, including soft tissue, bone, and visceral lesions, showing common involvement of the EWSR1 gene","volume":"49","author":"Antonescu","year":"2010","journal-title":"Genes Chromosom Cancer"},{"key":"R48-20250608","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s12105-013-0462-z","article-title":"Fusion oncogenes in salivary gland tumors: molecular and clinical consequences","volume":"7","author":"Stenman","year":"2013","journal-title":"Head Neck Pathol"},{"key":"R49-20250608","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/modpathol.2011.86","article-title":"Analysis of MYB expression and MYB-NFIB gene fusions in adenoid cystic carcinoma and other salivary neoplasms","volume":"24","author":"Brill","year":"2011","journal-title":"Mod Pathol"},{"key":"R50-20250608","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4132\/jptm.2018.10.12","article-title":"PLAG1, SOX10, and Myb expression in benign and malignant salivary gland neoplasms","volume":"53","author":"Lee","year":"2019","journal-title":"J Pathol Transl Med"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002307","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T20:01:32Z","timestamp":1749412892000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002307"}},"subtitle":["An Analysis of 84 Cases With a Novel HMGA2::LINC02389 Fusion"],"short-title":[],"issued":{"date-parts":[[2024,9,26]]},"references-count":49,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002307","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,26]]}}}